[PDF][PDF] Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib
PG Richardson, H Briemberg, S Jagannath, PY Wen… - J Clin Oncol, 2006 - Citeseer
PG Richardson, H Briemberg, S Jagannath, PY Wen, B Barlogie, J Berenson, S Singhal…
J Clin Oncol, 2006•CiteseerFrequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of
Advanced Multiple Myeloma With Bortez Page 1 Frequency, Characteristics, and Reversibility
of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib
Paul G. Richardson, Hannah Briemberg, Sundar Jagannath, Patrick Y. Wen, Bart Barlogie,
James Berenson, Seema Singhal, David S. Siegel, David Irwin, Michael Schuster, Gordan
Srkalovic, Raymond Alexanian, S. Vincent Rajkumar, Steven Limentani, Melissa Alsina …
Advanced Multiple Myeloma With Bortez Page 1 Frequency, Characteristics, and Reversibility
of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib
Paul G. Richardson, Hannah Briemberg, Sundar Jagannath, Patrick Y. Wen, Bart Barlogie,
James Berenson, Seema Singhal, David S. Siegel, David Irwin, Michael Schuster, Gordan
Srkalovic, Raymond Alexanian, S. Vincent Rajkumar, Steven Limentani, Melissa Alsina …
Purpose
To determine the frequency, characteristics, and reversibility of peripheral neuropathy from bortezomib treatment of advanced multiple myeloma.
Citeseer